Enfusion (ENFN) News Today → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free ENFN Stock Alerts $9.29 -0.06 (-0.64%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnfusion Announces Date of First Quarter 2024 Resultsbusinesswire.com - April 18 at 8:30 AMEnfusion Inc Class Amorningstar.com - April 17 at 9:12 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNprnewswire.com - April 12 at 2:40 PMVanguard Group Inc. Purchases 512,479 Shares of Enfusion, Inc. (NYSE:ENFN)marketbeat.com - April 12 at 4:08 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNprnewswire.com - April 4 at 7:15 PMThe 3 Most Undervalued Under-$10 Stocks to Buy in April 2024msn.com - April 4 at 7:13 AMWill Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?finance.yahoo.com - April 2 at 10:49 AMConnexPay Appoints Ben Peters as Chief Executive Officerbusinesswire.com - April 2 at 7:30 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNprnewswire.com - March 27 at 5:25 PMEnfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic Challengesmarkets.businessinsider.com - March 22 at 1:49 AMAnalysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)markets.businessinsider.com - March 21 at 3:44 PMStifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)markets.businessinsider.com - March 20 at 7:43 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFNprnewswire.com - March 19 at 5:20 PMEnfusion, Inc. (NYSE:ENFN) Receives Consensus Recommendation of "Reduce" from Analystsmarketbeat.com - March 18 at 5:12 PMWall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024markets.businessinsider.com - March 15 at 7:51 AMBrokers Set Expectations for Enfusion, Inc.'s Q1 2025 Earnings (NYSE:ENFN)marketbeat.com - March 15 at 7:47 AMEnfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 14 at 2:24 PMEnfusion (NYSE:ENFN) Shares Gap Down to $9.32marketbeat.com - March 14 at 11:56 AMEnfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 14 at 9:23 AMAnalysts Offer Insights on Technology Companies: Copperleaf Tech (OtherCPLFF), Rackspace Technology (RXT) and Enfusion (ENFN)markets.businessinsider.com - March 13 at 2:26 PMWilliam Blair Reaffirms Their Buy Rating on Enfusion (ENFN)markets.businessinsider.com - March 12 at 10:52 PMEnfusion reports mixed Q4 results; initiates FY24 outlookmsn.com - March 12 at 12:50 PMEnfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Resultsfinance.yahoo.com - March 12 at 7:49 AMEarnings Outlook For Enfusionbenzinga.com - March 11 at 4:22 PMMajor Purchase Alert: Oleg Movchan Invests $120K In Enfusion Stockbenzinga.com - March 6 at 5:35 PMEnfusion (ENFN) Scheduled to Post Earnings on Tuesdaymarketbeat.com - March 5 at 1:49 AMGoldman Sachs Downgrades Enfusion (ENFN)msn.com - February 29 at 3:22 PMEnfusion stock retreats after Goldman downgrades to Sellmsn.com - February 28 at 1:56 PMEnfusion Stock Sell Rating: Conservative Revenue Growth and Market Challenges Aheadmarkets.businessinsider.com - February 28 at 8:56 AMEnfusion (NYSE:ENFN) Cut to Sell at The Goldman Sachs Groupmarketbeat.com - February 28 at 7:16 AMArteris, Inc. (AIP) Reports Q4 Loss, Tops Revenue Estimatesmsn.com - February 20 at 8:43 PMEnfusion Breaks Above 200-Day Moving Average - Bullish for ENFNnasdaq.com - February 17 at 11:07 PMEnfusion Announces Date of Fourth Quarter and Full Year 2023 Resultsfinance.yahoo.com - February 13 at 9:56 AMEnfusion to Host Investor Day on March 19, 2024finance.yahoo.com - February 12 at 8:54 AMTrust of tech CEO sells Boca Raton mansion for $29 millionbizjournals.com - February 8 at 1:20 PMNew York State Common Retirement Fund Boosts Stock Position in Enfusion, Inc. (NYSE:ENFN)marketbeat.com - February 7 at 5:44 AMEnfusion (NYSE:ENFN) Shares Gap Down to $8.50marketbeat.com - January 30 at 3:39 PMEnfusion downgraded to Underweight on client risks at JPMorganrealmoney.thestreet.com - January 30 at 12:38 PMJP Morgan Downgrades Enfusion: Here's What You Need To Knowmarkets.businessinsider.com - January 30 at 12:38 PMJPMorgan gets more bearish on Enfusion, downgrades sharesrealmoney.thestreet.com - January 30 at 7:38 AMEnfusion (NYSE:ENFN) Downgraded to "Underweight" at JPMorgan Chase & Co.marketbeat.com - January 30 at 7:16 AMEnfusion, Inc.: Enfusion Elevates Valeria Gutowski to Chief Accounting Officerfinanznachrichten.de - January 18 at 9:24 AMEnfusion: Product Is Sticky And Industry Is Hugeseekingalpha.com - January 18 at 9:24 AMEnfusion Elevates Valeria Gutowski to Chief Accounting Officerfinance.yahoo.com - January 18 at 9:24 AMHere's What's Concerning About Enfusion's (NYSE:ENFN) Returns On Capitalfinance.yahoo.com - January 17 at 9:20 AMInsider Selling: Enfusion, Inc. (NYSE:ENFN) Director Sells 1,770 Shares of Stockmarketbeat.com - January 12 at 9:19 PMEnfusion, Inc. (NYSE:ENFN) CEO Sells $11,952.85 in Stockmarketbeat.com - January 10 at 9:33 PMEnfusion, Inc. (NYSE:ENFN) Receives Consensus Rating of "Hold" from Analystsmarketbeat.com - December 27 at 6:17 AMEnfusion (ENFN) Receives a Buy from William Blairmarkets.businessinsider.com - December 23 at 9:39 AMPiper Sandler Boosts Enfusion (NYSE:ENFN) Price Target to $10.00marketbeat.com - December 20 at 2:29 PM Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. ENFN Media Mentions By Week ENFN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENFN News Sentiment▼0.000.43▲Average Computer and Technology News Sentiment ENFN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENFN Articles This Week▼12▲ENFN Articles Average Week Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BASE News PDFS News ZUO News SOUN News MOMO News OPRA News DCBO News VTEX News EVBG News GDYN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENFN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
